No one is in her yet. NICE TO meet you my friend!! $AURX .20?! ONLY 1.8 MILLION FLOAT!NOT-A-MISPRINT WHY DO INSIDERS OWN OVER 70% OF SHARES? UNKNOWN to 99.99999% of traders, moves on a air on a power scale less than a whisper #BIOTECH GEM. 6 INSIDERS just ADDED SHARES per the 7 January 3rd filings and I'm the only trader that knows (I guess)!!!!? 6 Form 4 filing silently out, NO ONE NOTICED. WHY?????? Last time I alerted it at .05 it ran to .575 in 5 days. Nothing has changed since then...oh wait 1 thing has changed, INSIDERS BOUGHT MORE SHARESSSSSS!
David Jorden: Peter Clausen: Eric Winzer: Scott Pittman: Lawrence Atinsky: Paul Mintz: ALL 6 just LOADED!! Exercise price ...wait for it... 40 CENTS!!! Shhhhh.
AURX is THE FIRST platelet & plasma therapy system TO BE CLEARED by the FDA for the management of ulcers & wounds of all types & all severities? https://t.co/yPfwfHL1V8????
Private placement at 30 cents and traders are ignoring this at 20 cents?! I'm compelled to ask myself do I have super vision or is everyone else using a Navigation system created by the 3 blind mice? What more can i say? I'm trying to keep it do simple a 4 year old could understand it.
$AURX why did SHEEDY CHARLES E purchase 5.2 million shares at 22 cents (that's over $1.1 million folks) to add to the 3 million he already owned? He graduated from Harvard Business school so trust me he has a LITTLE smarts, maybe a tiny bit of intelligence. https://t.co/vI58wsa8W8
why did Boyalife Investment Fund I, Inc just purchase 3.1 million shares at .22 (DO THE MATH) #biotech gem #stocks #stockmarket #stocktrading #BTC
The only thing common about common sense is that it's UNCOMMON.
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Gaithersburg, Maryland.
News 
Market Data 
Discover 
